Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali

Background. In 2010, mass vaccination with a then-new meningococcal A polysaccharide–tetanus toxoid protein conjugate vaccine (PsA-TT, or MenAfriVac) was undertaken in 1- to 29-year-olds in Bamako, Mali. Whether vaccination with PsA-TT effectively boosts tetanus immunity in a population with heterog...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Infect Dis
Huvudupphovsmän: Basta, Nicole E., Borrow, Ray, Berthe, Abdoulaye, Onwuchekwa, Uma, Dembélé, Awa Traoré Eps, Almond, Rachael, Frankland, Sarah, Patel, Sima, Wood, Daniel, Nascimento, Maria, Manigart, Olivier, Trotter, Caroline L., Greenwood, Brian, Sow, Samba O.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2015
Ämnen:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639490/
https://ncbi.nlm.nih.gov/pubmed/26553691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ513
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk